Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to FDMT Full portfolio

Position in FDMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,145,039
+$6,686,306 QoQ
Shares Held
687,597
+160.4% QoQ
Ownership
0.953%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 158 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FDMT Over Time

Shares Held

Position Value (USD)

Derivatives in FDMT

reported options exposure · as of Jun 30, 2026
CallValue
$2,679,950
CallShares
201,500
PutValue
$160,930
PutShares
12,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,678,386 across 436 Biotechnology names. FDMT ranks #104 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in FDMT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,145,039 687,597
2026-06-30 $2,679,950 201,500
2026-06-30 $160,930 12,100
2026-03-31 $220,647 23,700
2026-03-31 $2,458,733 264,096
2026-03-31 $272,783 29,300
2025-12-31 $149,167 19,889
2025-12-31 $117,750 15,700
2025-12-31 $264,750 35,300
2025-09-30 $109,494 12,600
2025-09-30 $201,608 23,200
2025-06-30 $59,360 16,000
2025-06-30 $713,205 192,239
2025-06-30 $140,238 37,800
2025-03-31 $83,334 25,800
2025-03-31 $106,267 32,900
2025-03-31 $1,069,810 331,211
2024-12-31 $3,370,362 605,092
2024-12-31 $182,139 32,700
2024-12-31 $256,777 46,100
2024-09-30 $407,537 37,700
2024-09-30 $1,379,874 127,648
2024-09-30 $376,188 34,800
2024-06-30 $216,197 10,300
2024-06-30 $123,841 5,900
2024-06-30 $1,536,425 73,198
2024-03-31 $143,370 4,500
2024-03-31 $2,335,338 73,300
2024-03-31 $2,810,975 88,229
2023-12-31 $375,985 18,558
2023-12-31 $123,586 6,100
2023-12-31 $512,578 25,300
2023-09-30 $68,742 5,400
2023-09-30 $61,104 4,800
2023-09-30 $1,823,190 143,220
2023-06-30 $182,507 10,100
2023-06-30 $216,840 12,000
2023-06-30 $341,251 18,885
2023-03-31 $83,749 4,872
2023-03-31 $195,966 11,400
2023-03-31 $118,611 6,900
2022-12-31 $428,653 19,300
2022-12-31 $208,774 9,400
2022-09-30 $984,569 122,459
2022-09-30 $718,776 89,400
2022-06-30 $787,344 112,800
2022-06-30 $1,570,094 224,942
2022-03-31 $1,168,776 77,300
2022-03-31 $733,818 48,533
2021-12-31 $215,012 9,800

Report a Problem

Category
Description
Email (optional, for follow-up)